• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮功能障碍的表观遗传学能否代表 2 型糖尿病精准医学的关键?

Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?

机构信息

Department of Biomedical Science and Human Oncology, University of Bari "Aldo Moro", 70124 Bari, Italy.

Laboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo (Foggia), Italy.

出版信息

Int J Mol Sci. 2019 Jun 17;20(12):2949. doi: 10.3390/ijms20122949.

DOI:10.3390/ijms20122949
PMID:31212911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6628049/
Abstract

In both developing and industrialized Countries, the growing prevalence of Type 2 Diabetes Mellitus (T2DM) and the severity of its related complications make T2DM one of the most challenging metabolic diseases worldwide. The close relationship between genetic and environmental factors suggests that eating habits and unhealthy lifestyles may significantly affect metabolic pathways, resulting in dynamic modifications of chromatin-associated proteins and homeostatic transcriptional responses involved in the progression of T2DM. Epigenetic mechanisms may be implicated in the complex processes linking environmental factors to genetic predisposition to metabolic disturbances, leading to obesity and type 2 diabetes mellitus (T2DM). Endothelial dysfunction represents an earlier marker and an important player in the development of this disease. Dysregulation of the endothelial ability to produce and release vasoactive mediators is recognized as the initial feature of impaired vascular activity under obesity and other insulin resistance conditions and undoubtedly concurs to the accelerated progression of atherosclerotic lesions and overall cardiovascular risk in T2DM patients. This review aims to summarize the most current knowledge regarding the involvement of epigenetic changes associated with endothelial dysfunction in T2DM, in order to identify potential targets that might contribute to pursuing "precision medicine" in the context of diabetic illness.

摘要

在发展中国家和工业化国家,2 型糖尿病(T2DM)的患病率不断上升,以及其相关并发症的严重程度,使得 T2DM 成为全球最具挑战性的代谢性疾病之一。遗传和环境因素之间的密切关系表明,饮食习惯和不健康的生活方式可能会对代谢途径产生重大影响,导致与 T2DM 进展相关的染色质相关蛋白和稳态转录反应的动态改变。表观遗传机制可能与将环境因素与代谢紊乱的遗传易感性联系起来的复杂过程有关,导致肥胖和 2 型糖尿病(T2DM)。内皮功能障碍是该疾病发展的早期标志物和重要参与者。在肥胖和其他胰岛素抵抗情况下,内皮产生和释放血管活性介质的能力失调被认为是血管活性受损的最初特征,这无疑加速了 T2DM 患者动脉粥样硬化病变的进展和整体心血管风险。本综述旨在总结与 T2DM 内皮功能障碍相关的表观遗传变化的最新知识,以确定可能有助于在糖尿病疾病背景下追求“精准医学”的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e409/6628049/11c4062cd5e0/ijms-20-02949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e409/6628049/c5603f80f47c/ijms-20-02949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e409/6628049/11c4062cd5e0/ijms-20-02949-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e409/6628049/c5603f80f47c/ijms-20-02949-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e409/6628049/11c4062cd5e0/ijms-20-02949-g002.jpg

相似文献

1
Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?内皮功能障碍的表观遗传学能否代表 2 型糖尿病精准医学的关键?
Int J Mol Sci. 2019 Jun 17;20(12):2949. doi: 10.3390/ijms20122949.
2
Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine?2 型糖尿病和体重变化的表观遗传学——精准医学的工具?
Nat Rev Endocrinol. 2022 Jul;18(7):433-448. doi: 10.1038/s41574-022-00671-w. Epub 2022 May 5.
3
Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics.2 型糖尿病与心血管风险:药物治疗如何通过表观遗传学改变。
Postgrad Med. 2020 Mar;132(2):109-125. doi: 10.1080/00325481.2019.1681215. Epub 2019 Oct 29.
4
Extracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?细胞外微小RNA与内皮细胞高血糖记忆:一个治疗契机?
Diabetes Obes Metab. 2016 Sep;18(9):855-67. doi: 10.1111/dom.12688. Epub 2016 Jun 22.
5
The endothelium and vascular inflammation in diabetes.糖尿病中的内皮细胞与血管炎症
Diab Vasc Dis Res. 2007 Jun;4(2):84-8. doi: 10.3132/dvdr.2007.025.
6
Personalized medicine and type 2 diabetes: lesson from epigenetics.个体化医学与 2 型糖尿病:表观遗传学的启示。
Epigenomics. 2014 Apr;6(2):229-38. doi: 10.2217/epi.14.10.
7
Epigenetic flexibility in metabolic regulation: disease cause and prevention?代谢调控中的表观遗传灵活性:疾病的病因和预防?
Trends Cell Biol. 2013 May;23(5):203-9. doi: 10.1016/j.tcb.2012.11.008. Epub 2012 Dec 29.
8
Novel epigenetic-sensitive clinical challenges both in type 1 and type 2 diabetes.1 型和 2 型糖尿病中新的表观遗传敏感的临床挑战。
J Diabetes Complications. 2018 Nov;32(11):1076-1084. doi: 10.1016/j.jdiacomp.2018.08.012. Epub 2018 Aug 19.
9
Unraveling the epigenetic fabric of type 2 diabetes mellitus: pathogenic mechanisms and therapeutic implications.解析 2 型糖尿病的表观遗传学机制:发病机制与治疗意义。
Front Endocrinol (Lausanne). 2024 Jan 22;15:1295967. doi: 10.3389/fendo.2024.1295967. eCollection 2024.
10
The Importance of Precision Medicine in Type 2 Diabetes Mellitus (T2DM): From Pharmacogenetic and Pharmacoepigenetic Aspects.精准医学在2型糖尿病(T2DM)中的重要性:从药物遗传学和药物表观遗传学角度
Endocr Metab Immune Disord Drug Targets. 2019;19(6):719-731. doi: 10.2174/1871530319666190228102212.

引用本文的文献

1
Established and Emerging Roles of Epigenetic Regulation in Diabetic Cardiomyopathy.表观遗传调控在糖尿病心肌病中的既定作用与新出现的作用
Diabetes Metab Res Rev. 2025 Sep;41(6):e70081. doi: 10.1002/dmrr.70081.
2
New discoveries in therapeutic targets and drug development pathways for type 2 diabetes mellitus under the guidance of precision medicine.精准医学指导下2型糖尿病治疗靶点与药物研发途径的新发现
Eur J Med Res. 2025 Jun 4;30(1):450. doi: 10.1186/s40001-025-02682-5.
3
Tissue nanotransfection-based endothelial PLCγ2-targeted epigenetic gene editing rescues perfusion and diabetic ischemic wound healing.

本文引用的文献

1
Influences of up-regulation of miR-126 on septic inflammation and prognosis through AKT/Rac1 signaling pathway.miR-126 的上调通过 AKT/Rac1 信号通路对脓毒症炎症及预后的影响。
Eur Rev Med Pharmacol Sci. 2019 Mar;23(5):2132-2138. doi: 10.26355/eurrev_201903_17257.
2
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.糖尿病肾病和代谢记忆中的表观遗传学和表观基因组学。
Nat Rev Nephrol. 2019 Jun;15(6):327-345. doi: 10.1038/s41581-019-0135-6.
3
Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway.
基于组织纳米转染的内皮细胞PLCγ2靶向表观遗传基因编辑可挽救灌注并促进糖尿病缺血性伤口愈合。
Mol Ther. 2025 Mar 5;33(3):950-969. doi: 10.1016/j.ymthe.2025.01.034. Epub 2025 Jan 25.
4
Bridging the Gap: Endothelial Dysfunction and the Role of iPSC-Derived Endothelial Cells in Disease Modeling.弥合差距:内皮功能障碍与诱导多能干细胞衍生的内皮细胞在疾病建模中的作用
Int J Mol Sci. 2024 Dec 11;25(24):13275. doi: 10.3390/ijms252413275.
5
Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications.糖尿病合并糖尿病肾病并发症患者氧化应激的生物标志物。
Int J Mol Sci. 2023 Aug 31;24(17):13541. doi: 10.3390/ijms241713541.
6
microRNAs as Biomarkers of Endothelial Dysfunction and Therapeutic Target in the Pathogenesis of Atrial Fibrillation.微小 RNA 作为血管内皮功能障碍的生物标志物及其在心房颤动发病机制中的治疗靶点。
Int J Mol Sci. 2023 Mar 10;24(6):5307. doi: 10.3390/ijms24065307.
7
Diabetes and Its Cardiovascular Complications: Potential Role of the Acetyltransferase p300.糖尿病及其心血管并发症:乙酰转移酶 p300 的潜在作用。
Cells. 2023 Jan 28;12(3):431. doi: 10.3390/cells12030431.
8
The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges.当前细菌肺炎中 microRNAs(miRNAs)的研究现状:机遇与挑战。
Cell Mol Biol Lett. 2022 Aug 19;27(1):70. doi: 10.1186/s11658-022-00368-y.
9
To the Future: The Role of Exosome-Derived microRNAs as Markers, Mediators, and Therapies for Endothelial Dysfunction in Type 2 Diabetes Mellitus.展望未来:外泌体衍生 microRNAs 在 2 型糖尿病内皮功能障碍中的作为标志物、介质和治疗手段的作用。
J Diabetes Res. 2022 Feb 21;2022:5126968. doi: 10.1155/2022/5126968. eCollection 2022.
10
Salvianolic acid B alleviates diabetic endothelial and mitochondrial dysfunction by down-regulating apoptosis and mitophagy of endothelial cells.丹酚酸 B 通过下调内皮细胞凋亡和自噬来缓解糖尿病内皮和线粒体功能障碍。
Bioengineered. 2022 Feb;13(2):3486-3502. doi: 10.1080/21655979.2022.2026552.
组蛋白去乙酰化酶抑制剂曲古抑菌素 A 通过抑制 ERK 通路协同增强紫杉醇诱导的尿路上皮癌细胞的细胞毒性。
Int J Mol Sci. 2019 Mar 7;20(5):1162. doi: 10.3390/ijms20051162.
4
Inhibition of P53/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1.抑制 P53/miR-34a 通过激活 SIRT1 改善糖尿病内皮功能障碍。
J Cell Mol Med. 2019 May;23(5):3538-3548. doi: 10.1111/jcmm.14253. Epub 2019 Feb 22.
5
MicroRNA Manipulation to Boost Endothelial Regeneration: Are We Ready for the Next Steps?操纵微小RNA以促进内皮细胞再生:我们是否准备好迈出下一步?
Diabetes. 2019 Feb;68(2):268-270. doi: 10.2337/dbi18-0044.
6
Anagliptin ameliorates high glucose- induced endothelial dysfunction via suppression of NLRP3 inflammasome activation mediated by SIRT1.阿那格列汀通过 SIRT1 抑制 NLRP3 炎性小体激活改善高糖诱导的内皮功能障碍。
Mol Immunol. 2019 Mar;107:54-60. doi: 10.1016/j.molimm.2019.01.006. Epub 2019 Jan 17.
7
Exosomes and diabetes.外泌体与糖尿病。
Diabetes Metab Res Rev. 2019 Mar;35(3):e3107. doi: 10.1002/dmrr.3107. Epub 2019 Jan 7.
8
Therapeutic potential of selective histone deacetylase 3 inhibition.选择性组蛋白去乙酰化酶 3 抑制的治疗潜力。
Eur J Med Chem. 2019 Jan 15;162:534-542. doi: 10.1016/j.ejmech.2018.10.072. Epub 2018 Nov 17.
9
The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review.晚期糖基化终产物在糖尿病患者和非糖尿病患者冠状动脉疾病发生发展中的作用:综述
Mol Med. 2018 Nov 23;24(1):59. doi: 10.1186/s10020-018-0060-3.
10
miRBase: from microRNA sequences to function.miRBase:从 microRNA 序列到功能。
Nucleic Acids Res. 2019 Jan 8;47(D1):D155-D162. doi: 10.1093/nar/gky1141.